4563.T
AnGes,Inc.
グロース · 医薬品 · 医薬品 · JP
JPY 39.00
+0.00%Year over year
Reported trailing growth
- Revenue
- +35.9%
- EBITDA
- —
- EBIT
- +43.5%
- EPS
- +87.3%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +0.7%
- EBITDA
- —
- EPS
- -14.3%
Three-year CAGR
- Revenue
- +135.4%
- EBITDA
- +43.8%
- EBIT
- +43.5%
- Net income
- +81.8%
- EPS
- +87.9%
- Free cash flow
- +13.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026